In vitro evidence suggests that immune complex formation in IgA nephropathy is determined ... residues in this region renders the IgA1 molecule immunogenic.

a small molecule inhibitor designed to treat glomerular diseases with abnormal complement activation, such as IgA nephropathy. This development underscores the company’s commitment to advancing ...